Humana (NYSE:HUM) Price Target Lowered to $381.00 at Jefferies Financial Group

Humana (NYSE:HUM) had its target price cut by Jefferies Financial Group from $411.00 to $381.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the insurance provider’s stock.

HUM has been the subject of several other reports. Oppenheimer reissued an outperform rating and set a $630.00 target price on shares of Humana in a research note on Wednesday, January 17th. Royal Bank of Canada lowered their target price on Humana from $507.00 to $415.00 and set an outperform rating for the company in a research note on Friday, January 26th. Raymond James assumed coverage on Humana in a research note on Friday, March 22nd. They set a market perform rating for the company. Bank of America reissued a neutral rating and set a $342.00 target price (down from $470.00) on shares of Humana in a research note on Tuesday, April 2nd. Finally, TD Cowen lowered their target price on Humana from $427.00 to $396.00 and set a buy rating for the company in a research note on Tuesday, April 2nd. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Humana currently has a consensus rating of Hold and an average target price of $454.63.

Humana Price Performance

HUM stock opened at $325.30 on Monday. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $39.25 billion, a PE ratio of 16.41, a P/E/G ratio of 1.92 and a beta of 0.45. Humana has a 12-month low of $299.23 and a 12-month high of $541.21. The business’s fifty day moving average price is $330.09 and its 200 day moving average price is $399.70.

Humana (NYSE:HUM) last posted its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.87). The firm had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. Humana’s quarterly revenue was up 17.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.62 EPS. On average, sell-side analysts anticipate that Humana will post 16.06 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.09%. Humana’s dividend payout ratio is presently 17.86%.

Insiders Place Their Bets

In related news, Director Jorge S. Mesquita acquired 545 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the transaction, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.29% of the stock is owned by insiders.

Institutional Trading of Humana

A number of hedge funds have recently added to or reduced their stakes in the stock. Dorsey & Whitney Trust CO LLC lifted its position in Humana by 2.6% during the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock worth $397,000 after acquiring an additional 21 shares during the period. UMB Bank n.a. lifted its holdings in shares of Humana by 2.8% in the 3rd quarter. UMB Bank n.a. now owns 805 shares of the insurance provider’s stock valued at $392,000 after buying an additional 22 shares during the period. First Financial Corp IN lifted its holdings in shares of Humana by 7.2% in the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after buying an additional 23 shares during the period. PDS Planning Inc lifted its holdings in shares of Humana by 4.1% in the 3rd quarter. PDS Planning Inc now owns 609 shares of the insurance provider’s stock valued at $296,000 after buying an additional 24 shares during the period. Finally, First Trust Direct Indexing L.P. lifted its holdings in shares of Humana by 0.8% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock valued at $1,424,000 after buying an additional 24 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.